118 related articles for article (PubMed ID: 29469718)
1. Eccrine squamous syringometaplasia in an allogenic stem cell transplant patient undergoing chemotherapy.
Nethers K; Messina J; Seminario-Vidal L
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469718
[TBL] [Abstract][Full Text] [Related]
2. Vemurafenib-induced eccrine squamous syringometaplasia.
Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced eccrine squamous syringometaplasia. A distinctive eruption in patients receiving hematopoietic progenitor cells.
Valks R; Fraga J; Porras-Luque J; Figuera A; Garcia-Diéz A; Fernändez-Herrera J
Arch Dermatol; 1997 Jul; 133(7):873-8. PubMed ID: 9236526
[TBL] [Abstract][Full Text] [Related]
4. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
Wrzesień-Kuś A; Robak T; Wierzbowska A; Lech-Marańda E; Pluta A; Wawrzyniak E; Krawczyńska A; Kuliczkowski K; Mazur G; Kiebiński M; Dmoszyńska A; Wach M; Hellmann A; Baran W; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S;
Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
7. [Eccrine squamous syringometaplasia from chemotherapy extravasation].
Bordel MT; Miranda A
Actas Dermosifiliogr; 2005 Sep; 96(7):462-4. PubMed ID: 16476276
[TBL] [Abstract][Full Text] [Related]
8. Eccrine squamous syringometaplasia in intertriginous areas.
Valks R; Buezo GF; Daudén E; Fraga J; García-Díez A
Br J Dermatol; 1996 May; 134(5):984-6. PubMed ID: 8736357
[No Abstract] [Full Text] [Related]
9. A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature.
Tsuboi H; Yonemoto K; Katsuoka K
J Dermatol; 2005 Nov; 32(11):921-5. PubMed ID: 16361756
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced eccrine squamous syringometaplasia in an infant.
Bittar PG; Casady M; Selim MA; Prose NS
Pediatr Dermatol; 2018 Jan; 35(1):e84-e85. PubMed ID: 29231256
[TBL] [Abstract][Full Text] [Related]
11. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
12. Necrotizing eccrine squamous syringometaplasia presenting as acral erythema.
Rongioletti F; Ballestrero A; Bogliolo F; Rebora A
J Cutan Pathol; 1991 Dec; 18(6):453-6. PubMed ID: 1774355
[TBL] [Abstract][Full Text] [Related]
13. Leukemia cutis and eccrine squamous syringometaplasia.
Bouceiro-Mendes R; Antunes-Duarte S; Aguado-Lobo M; Espinosa-Lara P; Soares-de-Almeida L; Filipe P
Dermatol Online J; 2021 Jun; 27(6):. PubMed ID: 34387058
[TBL] [Abstract][Full Text] [Related]
14. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis'.
Hurt MA; Halvorson RD; Petr FC; Cooper JT; Friedman DJ
Arch Dermatol; 1990 Jan; 126(1):73-7. PubMed ID: 2404465
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen-induced eccrine squamous syringometaplasia.
Teoh DC; Aw DC; Jaffar H; Ling W; Yong WP; Lee YS; Choo SN; Tan KB
J Cutan Pathol; 2012 May; 39(5):554-7. PubMed ID: 22390276
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
Kantarjian HM; Talpaz M; Kontoyiannis D; Gutterman J; Keating MJ; Estey EH; O'Brien S; Rios MB; Beran M; Deisseroth A
J Clin Oncol; 1992 Mar; 10(3):398-405. PubMed ID: 1740679
[TBL] [Abstract][Full Text] [Related]
17. [Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
Katagiri T; Miyazawa K; Uchida Y; Hayashi S; Iwama H; Shyohji N; Kawakubo K; Shimamoto T; Inatomi Y; Kuriyama Y; Yaguchi M; Nehashi Y; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1998 Dec; 39(12):1149-56. PubMed ID: 10028846
[TBL] [Abstract][Full Text] [Related]
18. Ciliated and Mucinous Adenomatous Syringometaplasia: The Missing Link of the "Ciliated Eccrine Metaplasia" Theory in the Histogenesis of Cutaneous Eccrine Ciliated Cyst?
Tran TAN
Am J Dermatopathol; 2021 Nov; 43(11):827-830. PubMed ID: 33606368
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic chemotherapy, sweat, and the skin.
Horn TD
Arch Dermatol; 1997 Jul; 133(7):905-6. PubMed ID: 9236531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
